Selexipag + Rifampin Interaction
Moderateinteraction on record
Description
CYP2C8 inducer that halved active metabolite exposure. Increase selexipag dose up to twice when co-administered; reduce when rifampin is stopped.
Mechanism
CYP2C8 and UGT1A3/2B7 induction
Source: NLP:selexipag